Expanded Access [11C] Methionine PET Imaging

Status Available

Clinical Trial Summary

The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment. Primary Objective To provide expanded access to L-[11C]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and head and neck to guide therapeutic management of disease.

Clinical Trial Description

Participants receive an intravenous injection of a small (tracer) dose of L-[11C]methionine. Approximately 10 minutes later, patients undergo PET scanning to evaluate localization of the tracer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05511714
Study type	Expanded Access
Source	St. Jude Children's Research Hospital
Contact	Barry L. Shulkin, MD, MBA
Phone	866-278-5833
Email	referralinfo@stjude.org
Status	Available
Phase

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05980598` - TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma	Phase 2
Completed	`NCT02548377` - Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial	N/A
Active, not recruiting	`NCT02229656` - Olaparib and Radiotherapy in Head and Neck Cancer	Phase 1
Not yet recruiting	`NCT06289049` - Heavy Strength Training in Head and Neck Cancer Survivors	Phase 2
Not yet recruiting	`NCT06347185` - Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study	N/A
Terminated	`NCT02975739` - Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors	N/A
Recruiting	`NCT00982436` - Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT01025518` - DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients	N/A
Active, not recruiting	`NCT00248235` - Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer	Phase 2/Phase 3
Completed	`NCT00135161` - Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer	Phase 1
Terminated	`NCT00073450` - Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)	Phase 2
Not yet recruiting	`NCT06458517` - Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers	N/A
Completed	`NCT05269342` - Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer	N/A
Recruiting	`NCT05544136` - A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer	Phase 2
Terminated	`NCT03286972` - PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
Recruiting	`NCT04435938` - A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck	Phase 2
Recruiting	`NCT03678649` - A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC	Phase 2
Recruiting	`NCT03975465` - EMST and Swallowing in Long-Term Survivors of HNCA	N/A
Completed	`NCT03292250` - Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]	Phase 2
Completed	`NCT06446570` - Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma	Phase 2